Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Classical hematology × Clear all

NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Phase EARLY_PHASE1 Recruiting

Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT06398457 2025-09-26

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT06802146 2025-03-27

Early Intervention in High Risk CCUS

Phase EARLY_PHASE1 Recruiting

Classical hematology

Cytopenia

NCT02285738 2019-05-08

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Phase EARLY_PHASE1 Completed

Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

NCT00212407 2018-11-02

New York Blood Center National Cord Blood Program

Phase EARLY_PHASE1 Terminated

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Genetic Diseases, Inborn

NCT02805868 2016-10-24

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Phase EARLY_PHASE1 Withdrawn

Classical hematologyLymphoidMyeloid

Anemia, Lymphoma, Follicular, Polycythemia Vera, Thrombocytopenia, Thrombocytosis, Primary Myelofibrosis